Friday, June 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 181 of 1,261

  1. US 11707457

    IRAK degraders and uses thereof

    Kymera Therapeutics, Inc. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted

  2. US 11707550

    Polyphosphate-functionalized inorganic nanoparticles as hemostatic compositions and methods of use

    The Regents of the University of California · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted

  3. US 11707459

    Method for treating nervous system injuries using boldine and analogs thereof

    United States Government as represented by the Department of Veterans Affairs · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted

  4. US 11707447

    C4-carbonothioate-substituted tryptamine derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted

  5. US 11708333

    Human plasma kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted

  6. US 11707503

    Modulators of complement activity

    RA PHARMACEUTICALS, INC. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted

  7. US 11707472

    Compositions for the treatment of fibrosis

    Viking Therapeutics, Inc. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted

  8. US 11707346

    Dental mill blank and method for producing same

    KURARAY NORITAKE DENTAL INC. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted

  9. US 11708406

    Method of treating acute respiratory distress syndrome (ARDS) or acute lung injury (ALI) associate with COVID-19 by administering an anti-LIGHT antibody

    AVALO THERAPEUTICS, INC. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted

  10. US 11707434

    Method for preparing organic solvent-free lyophilized cyclophosphamide

    KOREA UNITED PHARM. INC. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted

  11. US 11707454

    Topical roflumilast formulation having antifungal properties

    ARCUTIS BIOTHERAPEUTICS, INC. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted

  12. US 11707535

    Method and composition for treating neuropathic pain

    The Regents of the University of California · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted

  13. US 11708332

    Human plasma kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted

  14. US 11708347

    Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted

  15. US 11708329

    Inhibitors of the WNT/beta-catenin pathway

    The Regents of the University of California · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted

  16. EP 4210672

    HYALURONSÄURE ODER SALZ DAVON ZUR INHALATION ZUR BEHANDLUNG VON ATEMWEGSERKRANKUNGEN UND INHALATORVORRICHTUNG DAMIT

    ALFASIGMA SPA [IT] · Granted Jul 19, 2023 · Expires Jul 14, 2043

    granted

  17. US 11702400

    Salt types, crystal forms, and preparation methods for benzopyrazole compounds as RHO kinase inhibitors

    Medshine Discovery Inc. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  18. US 11702411

    Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors

    Revolution Medicines, Inc. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  19. US 11702417

    Compounds for improving mRNA splicing

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  20. US 11701433

    Complexes for delivery of antigenic peptides

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  21. US 11702448

    Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers

    RHYTHM PHARMACEUTICALS, INC. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  22. US 11701431

    Hydrogel prodrug for treatment

    Viking Scientific, Inc. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  23. US 11702701

    Means and methods for staging, typing and treating a cancerous disease

    Universität Regensburg · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  24. US 11702646

    Methods for modulating RNA splicing

    PTC THERAPEUTICS, INC. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.